Accumulated indirect evidence suggests nerve growthpromoting activities for acetylcholinesterase (AChE). To determine unequivocally whether such activities exist, whether they are related to the capacities of this enzyme to hydrolyze acetylcholine and enhance synapse development, and whether they are associated with alternative splicing variants of AChEm-RNA, we used four recombinant human AChEDNA vectors. When Xenopus laevis embryos were injected with a vector expressing the synapse-characteristic human AChE-E6, which contains the exon 6-encoded C terminus, cultured spinal neurons expressing this enzyme grew threefold faster than cocultured control neurons. Similar enhancement occurred in neurons expressing an insertion-inactivated human AChE-E6-IN protein, containing the same C terminus, and displaying indistinguishable immunochemical and electrophoretic migration properties from AChE-E6, but incapable of hydrolyzing acetylcholine. In contrast, the nonsynaptic secretory human AChE-I4, which contains the pseudointron 4-derived C terminus, did not affect neurite growth. Moreover, no growth promotion occurred in neurons expressing the catalytically active C-terminally truncated human AChE-E4, demonstrating a dominant role for the E6-derived C terminus in neurite extension. Also, AChE-E6 was the only active enzyme variant to be associated with Xenopus membranes. However, postsynaptic length measurements demonstrated that both AChE-E6 and AChE-E4 enhanced the development of neuromuscular junctions in vivo, unlike the catalytically inert AChE-E6-IN and the nonsynaptic AChE-I4. These findings demonstrate an evolutionarily conserved synaptogenic activity for AChE that depends on its hydrolytic capacity but not on its membrane association. Moreover, this synaptogenic effect differs from the growth-promoting activity of AChE, which is unrelated to its hydrolytic capacity yet depends on its exon 6-mediated membrane association.
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Acetylcholinesterase (AChE) hydrolyzes the neurotransmitter acetylcholine (ACh) released from nerve terminals at neuromuscular junctions (NMJs) and brain cholinergic synapses, thus terminating synaptic transmission (Salpeter, 1967) . Potential noncatalytic f unctions of AChE were implicated by findings that certain AChE inhibitors decrease chick neurite outgrowth in culture and that externally added AChE stimulates this process regardless of the presence of specific inhibitors (Layer et al., 1993; Jones et al., 1995; Small et al., 1995) . Sequence homology between AChE and several adhesion molecules (de La Escalera et al., 1990; Auld et al., 1995; Ichtchenko et al., 1995) and the early appearance of AChE in developing embryos before the onset of cholinergic neurotransmission (Layer and Willbold, 1995) also suggest that AChE may play a developmental f unction in cellular development and neuronal growth that is unrelated to its classic ACh hydrolyzing activity. However, experiments aimed at the noncatalytic nature of the neurogenic activity of AChE were all based on the indirect use of inhibitors or involved external addition of AChE to the culture medium (Jones et al., 1995) or solid substrate (Layer et al., 1993; Small et al., 1995) . This called for studies in which the activity levels of AChE would be changed within the tested neurons themselves.
Human pre-AChEmRNA may be alternatively spliced at its 3Ј end to yield three mature AChEmRNAs encoding protein products with three distinct C termini (Ben Aziz-Aloya et al., 1993; Karpel et al., 1994) . These include the brain-abundant exon 6-encoded C-terminal peptide, the hematopoietic exon 5-encoded C terminus, which enables glycophospholipid attachment, and the C terminus derived from the open reading frame of the tumorabundant pseudointron 4. The brain and muscle human (h) AChE form (hAChE-E6), expressed in developing Xenopus laevis embryos, accumulates in and enlarges the postsynaptic length of neuromuscular junctions (NMJs) (Seidman et al., 1994; . Transgenic mice expressing hAChE-E6 show NMJ enlargement and late onset neuromotor deterioration (Andres et al., 1997) . In contrast, DNA encoding the read-through form of hAChEmRNA (ACHE-I4/E5) causes production and secretion of an enzyme C terminated by the I4-encoded peptide (hAChE-I4) in ciliated and secretory epidermal cells of Xenopus embryos. Moreover, hAChE-I4 did not reach NMJs or affect their length (Seidman et al., 1995) . When transfected into glioma cells, ACHE-I4/E5 caused the appearance of small, processless round cells, whereas hAChE-E6 transfection induced process extension (Karpel et al., 1996) . To explore the involvement of the catalytic activity and the alternative C termini of AChE in its neurogenic or synaptogenic activities, we constructed two novel hAChEDNA vectors. One of these encodes a truncated form of the enzyme, devoid of any of the natural C termini; the other encodes an insert-disrupted form of the enzyme, incapable of hydrolyzing ACh yet recognized by anti-AChE antibodies. These two constructs and the above hACH E-E6 and hACH E-I4/ E5 DNAs were microinjected into Xenopus oocytes and embryos. The biochemical and hydrodynamic properties of the resultant proteins were then compared with the effects of each of these AChE variants on neurite extension from spinal neurons and on in vivo NMJ development in Xenopus.
MATERIALS AND METHODS

Construction of vectors.
The plasmids referred to here as ACH E-E6 and ACH E-I4/ E5 have been described in detail (Ben Aziz-Aloya et al., 1993; Seidman et al., 1995) . To create a DNA construct encoding a truncated form of hAChE, lacking either of the native C termini, we used a two-phase PCR engineering procedure (Higuchi, 1990 ) using the recombinant human ACH E cDNA and genomic clones . In the first PCR phase, performed essentially as described (Karpel et al., 1994) , ACH E-E6 served as template. T wo partially overlapping products were produced in which ACH E exon 4 and the SV40 polyadenylation signal were joined together, using primers containing the overlapping sequence: E3/1522ϩ 5Ј-CGGCTCTACGCCTACGTCTTTGAACAC CGTGCTTC-3Ј; E4del4 -5Ј-TAACGTCGACTATCAGGTGGCGCTGA GCAATTTGGGGG-3Ј; E4del3ϩ 5Ј-TTGCTCAGCGCCACCTGATAGT CGACGTTAACTTGTTTATTGCAGCTTATAATGG-3Ј; SV40 PolyA-5ЈATGATTTGGACAAACCACAACTAGAATGCAGTG-3Ј. Primers were named according to their position in the human ACH E alternative sequences and vectors. After removal of the primers, the two products were combined into one longer product by a second PCR reaction in which they served as templates. E xternal primers E3/1522ϩ and SV40 polyAϪ were used in the second phase to create a fragment consisting of the 3Ј end of exon 3, exon 4, and the polyA signal. PCR reaction was as above except that in the first cycle the denaturing step was at 94°C for 5 min and the annealing step was from 94 to 50°C (slope rate of 1°C per 30 sec). The product and the original ACH E-E6 plasmid were restricted using enzymes NotI and SalI, and the two products were then ligated.
To construct the disrupted ACH E coding sequence we inserted an in-frame sequence of 21 nucleotides, six bases downstream of the codon for the active site serine, located in exon 2. The technique used was the same two-phase PCR described above. In the first PCR phase we used primers containing the inserted sequence. Primers used were E2/340ϩ 5Ј-GC TTTCC TGGGCATCCCC TTTGCGGAGCCA-3Ј; E2ins2-5Ј-TCC accgaattgaggatgtcgccacgcgctC TCCCCAAACAGCGT-3Ј; E2ins1ϩ 5Ј-AGCGCGtggcgacatcctcaattcggtggaGCCGCC TCGGCGGGCAT-3Ј; 1212-5Ј-GAAGTC TCCCGCGTTGATCAGGGCC TC TGG-3Ј. The inserted sequence is designated by lower case letters. Primers E2/340ϩ and E2ins2Ϫ were used to link the inserted sequence to the upstream PCR product, and primers E2ins1ϩ and E2/1212Ϫ were used to link it to the downstream product. The second PCR phase was performed using external primers E2/340ϩ and E2/1212Ϫ. Stage II PCR products and ACH E-E6 were restricted using enzymes BstEII and SphI and ligated. First and second phase PCR reactions were as above. After construction, the accuracy and integrity of both constructs was validated by DNA sequencing.
Recombinant AChE production and assays of hydrol ytic activit y. Xenopus oocytes were microinjected with 10 ng of DNA of each recombinant AChE plasmid, incubated for 48 hr, and homogenized in high-saltdetergent buffer as described previously . Homogenates were frozen until use. AChE activity was measured by evaluating acetylthiocholine (ATCh) hydrolysis using 96-well microtiter plates. pH dependence of AChE activity was assessed using phosphate buffer at the pH range 5.8 -8.0, with intervals of 0.2. For K m and substrate inhibition experiments, we used ATCh in the concentration range of 0.05-60 mM and the GraFit 3.0 program (Erithacus Software limited, Staines, UK).
For enzyme stability studies, oocyte homogenates were incubated at 19 -42°C for 0 -5 hr, after which AChE catalytic activities in each of the homogenates were assessed as above.
Xenopus embryo microinjection and subcellular fractionation. In vitro fertilization of mature Xenopus eggs and blastomere microinjection were performed as described elsewhere (Seidman et al., 1994) , except that embryos were raised in 19 -21°C. Subcellular fractionation of 1-, 2-, and 3-d-old embryos into low-salt (0.01 M Tris-HCl, pH 7.4, 0.05 M MgCl 2 , 144 mM NaCl), low-salt-detergent (1% Triton X-100 in 0.01 M sodium phosphate, pH 7.4), and high-salt (1 M NaCl in 0.01 M sodium phosphate, pH 7.4) buffers was performed as described previously (Seidman et al., 1994) .
Protein blot anal yses and immunoc ytochemistr y. Denaturing SDS-PAGE and blotting were essentially as described elsewhere (Seidman et al., 1994) , except that after transfer the blots were washed with 1ϫ PBS (80 mM NaH 2 PO 4 , 20 mM Na 2 HPO 4 , pH 7.4), 0.5% T ween-20, 18% glucose, 10% glycerol, 2.5% bovine serum albumin, and 1% skim milk. Immunodetection was performed using a pool of monoclonal antibodies (132-1,2,3; 6 g /ml each) raised against denatured human brain AChE, and a 1:2 ϫ 10 4 dilution of a horseradish -peroxidase-conjugated sheep anti-mouse IgG (Jackson Laboratories, Bar Harbor, M E). Chemiluminescent detection was performed with the ECL kit (Amersham Life Sciences) as instructed. Ten microliter samples of oocyte homogenate (equivalent to ϳ50 ng AChE) were loaded on each lane. For enzyme activity blots, we used nondenaturing gel electrophoresis followed by incubation in ATCh staining mixture (Seidman et al., 1995) , using similar amounts of oocyte homogenates.
For immunochemical AChE detection in situ, cells were fixed with 2% paraformaldehyde in PBS for 30 min at room temperature and then permeabilized with 0.1% Triton X-100 (20 min). After they were washed with TBST (10 mM Tris-HC l, pH 7.0, 150 mM NaC l, 0.05% T ween-20), cells were incubated with anti-human AChE antibodies (mouse monoclonal antibody 132-1; 1:1000 dilution in TBST containing 10% normal goat serum) at 4°C overnight. After washes with TBST (5 ϫ 30 min), cells were incubated with goat anti-mouse IgG conjugated to fluorescein (Sigma) (1:100 in TBST containing 10% normal goat serum) at 22°C for 2 hr. After the same washing procedure as described above, cells were mounted and observed under a Nikon Diaphot microscope with a 20ϫ/ 1.25 objective.
Culture preparation. Xenopus nerve -muscle cultures were prepared according to previously reported methods (Spitzer and Lamborghini, 1976; Anderson et al., 1977; Tabti and Poo, 1995) . Briefly, neural tubes and the associated myotomal tissue of 1-d-old Xenopus embryos (stage 20 -23 according to Nieuwkoop and Faber, 1967) were dissociated in Ca 2ϩ -Mg 2ϩ -free saline supplemented with EDTA (115 mM NaC l, 2.6 mM KC l, 10 mM H EPES, 0.4 mM EDTA, pH 7.6) for 15-20 min. The cells were plated on glass coverslips and used for experiments after 6 hr of incubation at room temperature. The culture medium consisted (vol / vol) of 49% Leibovitz L -15 medium (Life Technologies, Gaithersburg, MD), 1% bovine serum (Life Technologies), and 50% Ringer's solution (115 mM NaC l, 2 mM CaCl 2 , 2.6 mM KC l, 10 mM H EPES, pH 7.6).
Neurite length measurements. Line drawings of isolated neurons and their neuritic processes were traced from the video monitor display of recorded microscopic images. The tip of the growing neurite was defined as the distal leading edge of the phase-dark palm of the growth cone, without considering the filopodial extension. The entire trajectory of the neurite, including all of its branches, was measured with a digitizing pad (Houston Instruments), and the total length of each neurite was calculated by a microcomputer. The rate of extension (micrometers per hour) was determined by dividing the net increase in neurite length (in micrometers) by the duration of observation (in hours).
Electron microscopy and morphometric anal yses. Histochemical staining, transmission electron microscopy, and morphometric analyses were performed as described previously (Ben Aziz-Aloya et al., 1993; Seidman et al., 1995) .
RESULTS
Construction and analyses of hAChE variants
To delineate functions and domains of AChE variants that are involved in neuron growth and synaptogenesis, two novel hACh-EDNA vectors were constructed by a two-phase PCR procedure (see Materials and Methods). One of these constructs, ACHE-E4 ( Fig. 1 A) , carries a truncated coding sequence containing exons 2, 3, and 4 of the human ACH E gene. The other construct, ACHE-E6-I N ( Fig. 1 A) , encodes a protein identical to the synapseaccumulating AChE-E6, except that it carries an in-frame insert of seven amino acids near the active site protein sequence, which should render it inactive. Similar to the previously used ACH E-E6 (Ben Aziz-Aloya et al., 1993) (Fig. 1 A) and ACHE-I4/E5 (Seidman et al., 1995) (Fig. 1 A) , transcription of both these constructs was regulated by the cytomegalovirus promoter, and they both contain the SV40 polyadenylation signal. Together, this set of four constructs enabled us to explore the biochemical and morphogenic activities of AChEs with three distinct C termini (encoded by E6, I4, or E4) and of the synaptic AChE-E6 enzyme with or without catalytic capacity.
For biochemical characterization of their protein products, all four plasmids were microinjected into Xenopus oocytes. The catalytic activity of the resultant proteins was then assessed by measuring the hydrolysis rate of acetylthiocholine (ATCh) in oocyte homogenates. As predicted, oocytes expressing the disrupted form, ACHE-E6-I N, displayed exceedingly low activity levels ( Fig. 1 B) , which were similar to those of the two experimental controls: buffer-injected and uninjected oocytes (not shown), most probably reflecting the endogenous Xenopus AChE activity levels. As expected, both natural AChE variants, terminated with the E6-encoded C terminus or with that encoded by I4, showed high activity levels ( Fig. 1 B) , confirming previous results (Schwarz et al., 1995a; Seidman et al., 1995) . The novel truncated form of AChE, encoded by ACHE-E4, displayed activity levels within the range of the other two variants (Fig. 1 B) . This demonstrated that neither of the natural C termini encoded by E6 or I4 is essential for the ACh hydrolytic activity of AChE.
Electrophoretic distinctions and hydrolytic similarities
In consideration of the possibility that the low activity levels observed for the ACHE-E6-IN homogenates did not reflect inactivation but were caused by impaired production of this protein in oocytes, we subjected the various recombinant hAChEs to denaturing gel electrophoresis followed by immunoblotting. Selective immunodetection of hAChE bands (Fig. 1C, top panel ) demonstrated that the Xenopus system is capable of producing AChE-E6-IN in size and amounts comparable to those of the ATCh hydrolyzing activities of each of the enzyme forms encoded by the above ACH E constructs were tested in homogenates of microinjected Xenopus oocytes. Presented are average results of three experiments for each construct. Endogenous Xenopus AChE activities were subtracted from activities found for cDNA-injected oocytes. Note that AChE-E4 activity levels are comparable with those of AChE-E6 and AChE-I4 and that AChE-E6-I N displayed no significant catalytic activity. C, Electrophoretic properties and antibody recognition of the AChE variants. Homogenates of Xenopus oocytes microinjected with each of the ACHE cDNA constructs and of control buffer-injected oocytes ( C) were subjected to denaturing gel electrophoresis followed by protein blot and immunodetection (top) and to nondenaturing gel electrophoresis followed by AChE activity staining (bottom). Each lane represents ϳ50 ng AChE. Note that AChE-E6-IN is highly immunoreactive but displays no catalytic activity and that AChE-E4 migrates faster than the other variants in the denaturing gel. In the bottom panel, note that AChE-I4 displays heterogeneous bands and migrates faster than AChE-E6 and AChE-E4. D, Substrate inhibition. The above oocyte homogenates were assayed for cholinesterase activity in the presence of 0.05-60 mM ATCh as substrate. Cholinesterase activity in each substrate concentration is shown as percentage of the highest activity for each homogenate, after subtraction of spontaneous ATCh hydrolysis. Shown is one representative of two experiments. Inset, K m values of the recombinant hAChE variants.
other AChE variants. The electrophoretic migration distance of all variants except AChE-E4 matched the expected molecular weight of 66 kDa, whereas AChE-E4 migrated somewhat faster, consistent with its truncated C terminus. Minor amounts of an immunopositive protein, with a migration distance similar to that of AChE-E4, could also be seen in the lanes loaded with the protein products of ACH E-E6 and ACH E-E6-I N (Fig. 1C, top  panel ) . C atalytic activity and intact C termini are therefore not obligatory requirements for production and stability of this protein in the Xenopus milieu.
When subjected to nondenaturing gel electrophoresis followed by AChE activity staining, the enzyme produced by ACHE-E6-I N showed no detectable catalytic activity, as opposed to the other variants, which were all highly active (Fig. 1C, bottom  panel ) . The migration of AChE-E6 was considerably slower and the band was much sharper than those of AChE-I4, which displayed faster migrating heterogeneous bands. AChE-E4 showed an intermediate band. The four tested hAChE variants thus differed in their Stokes radius and charge and active site conformation, whereas they maintained similar primary folding and production efficiency.
Having shown that ACH E-E6, ACH E-I4/ E5, and ACHE-E4 all encode for active enzymes, we wished to examine whether changing the C terminus of AChE did not affect its catalytic properties in a more subtle manner. Interestingly, the Xenopus enzyme retained its f ull catalytic activity after 5 hr at 42°C, whereas all hAChE variants lost 50% of their activity (not shown). However, all three hAChE variants were found to have K m values within the same range of the previously reported value (0.3 mM for AChE-E6 in Xenopus oocytes) (Seidman et al., 1994) and were similarly inhibited by high substrate concentrations (Fig.  1 D) . Also, substrate hydrolysis by all AChE forms was similarly enhanced within the pH range of 5.8 -8.0 (data not shown), in agreement with reports of others (for review, see Schwarz et al., 1995b) . There was therefore no indication whatsoever for involvement of the variable C termini of AChE in its catalytic properties, consistent with previous reports in which enzymatic cleavage of the C terminus was used to obtain a homogeneous catalytically active AChE preparation for x-ray diffraction analysis (Sussman et al., 1991) .
Expression of human AChE in Xenopus spinal neurons
Expression of hAChE in Xenopus embryonic neurons was examined after injection of each of the above hAChEDNA constructs into one of the blastomeres of two-cell stage Xenopus embryos. To facilitate identification of living neurons expressing hAChE during neurite growth assays, fluorescent dextran was co-injected with the DNA. The progeny neurons of the injected blastomere could then be identified by the presence of fluorescent dextran. Confirmation of AChE expression in individual spinal neurons was then obtained by immunocytochemical staining of the dissociated neurons from 1-d-old embryos, using monoclonal antibodies specific for hAChE (Seidman et al., 1995) . The reliability of fluorescent dextran as a marker for neurons overexpressing AChE was examined in the following experiment. Nerve-muscle cultures were prepared from embryos injected with ACHE-E6 cDNA and rhodamine -dextran. Dextran-positive neurons in 1-dold cultures were identified and recorded. The same cultures were then processed for immunocytochemical staining with antibodies against AChE. In control cultures prepared from embryos not injected with AChE-E6 cDNA, there was a negligible level of AChE staining. In cultures prepared from AChE-E6 cDNA and dextran-injected embryos, we found that 92% (36 of 39 cells) of dextran-positive neurons exhibited AChE staining, whereas 95% (55 of 58 cells) of dextran-negative neurons exhibited undetectable AChE staining. Figure 2 depicts examples of (AChEϩ) and (AChEϪ) neurons, together with their bright-field images at 7, 8, and 9 hr in culture, before the staining of AChE. In this culture, dextran-positive muscle cells also showed, as expected, elevated staining with AChE. Thus, immunostaining for hAChE shows that hAChE-E6 is expressed in these spinal neurons and that dextran fluorescence is a reliable marker for AChE expression.
Effects of expressing human AChE on neurite growth
Six hours after plating of dissociated Xenopus neural tube cells in culture, many spinal neurons exhibit active neurite outgrowth. Only isolated neurons not in contact with any other cell were used in this study, on which two types of neurite growth assays were made. First, the total neurite length of each neuron in the culture was measured. Second, extension of individual neurites was measured for a 3-4 hr period at 1 hr intervals (from 6 to 10 hr after plating). The hAChE-expressing (AChEϩ) neurons were identified by the presence of fluorescent dextran in the cell. To reduce culture-to-culture variation, similar numbers of (AChEϩ) and control neurons in the same culture or cultures from the same batch of embryos were examined. This analysis revealed that the average neurite length (the entire trajectory of the neurite, including all its branches) was 124.0 Ϯ 11.7 m (SEM; n ϭ 32) in (AChE-E6ϩ)-expressing neurons, which is significantly longer ( p Ͻ 0.001; two-tailed t test) than that observed for noninjected neurons (88.2 Ϯ 10.3 m; SEM; n ϭ 33) or AChE-I4-expressing neurons (77.5 Ϯ 8.2 m; SEM; n ϭ 27). To illustrate the overall difference in neurite growth for a large number of neurons, composite drawings were made by superimposing tracings of the video images of randomly chosen neurons, 15 from each of the noninjected control, (AChE-E6ϩ), and (AChE-I4ϩ) groups, respectively (Fig. 3) . It is clear from this figure that the net neurite extension over the first 9 hr in culture was substantially longer in (AChE-E6ϩ) neurons.
The higher total neurite length at a particular time in culture may reflect a higher growth rate of each neurite, an earlier onset of neurite outgrowth from the soma after cell plating, or both. Direct measurements of the growth rate of individual neurites during the 6 -10 hr period revealed that (AChE-E6ϩ) neurites indeed exhibit a higher growth rate. As shown in Table 1 , in the same group of cultures, the average growth rate was 12.9 Ϯ 2.7 m/hr (SEM; n ϭ 33) for noninjected control neurons but was elevated to 37.9 Ϯ 5.2 m/hr (SEM; n ϭ 32) for (AChE-E6ϩ) neurons, the difference being highly significant ( p Ͻ 0.005; twotailed t test). In contrast, neurons expressing the read-through form AChE-I4 did not show any difference in growth rate compared with the noninjected controls. The enhanced growth rate of (AChE-E6ϩ) neurons was sufficient to account for the difference in the overall neurite length described above, although earlier neurite initiation could also have occurred. In addition to the growth rate, we also measured the number of neuritic branches in each group of neurons. As shown in Table 1 , no significant difference was found between any of the groups.
Growth promotion is unrelated to ACh hydrolytic activity
Whether the growth-promoting effect on Xenopus neurons was partially or entirely caused by the catalytic activity of the enzyme in hydrolyzing ACh was tested by expressing AChE-E6-IN, the Figure 2 . Neurons expressing human AChE-E6 (ϩ) and control neurons (Ϫ) in Xenopus cultures. Xenopus embryos were co-injected with AChE-E6 DNA and rhodamine-dextran complexes, and their spinal neurons were dissociated into culture 1 d later. Bright-field images were taken at 7, 8, and 9 hr after cell plating. Both the total neurite length and the rate of neurite growth were measured during this period. Fluorescence micrographs on the right of the 9 hr photographs depict the rhodamine fluorescence of dextran complexes, which were co-injected with the cDNA. Indirect fluorescein immunofluorescence staining of AChE observed at the end of the experiment is shown on the last right panel. Note the correlation between dextran fluorescence and AChE staining. Staining and imaging conditions were identical for all four cells, which were from the same culture. Fluorescently labeled cells (ϩ) were positive with both red and green filters, whereas negative (Ϫ) cells remained invisible in both. Scale bar, 20 m.
insertion-inactivated form of AChE-E6, which lacks ACh hydrolytic activity (see above). As shown in Table 1 , (AChE-E6ϩ) and (ACH E-E6-I Nϩ) neurites were similar both in the total neurite length after 9 -10 hr in culture and in the rate of neurite growth during this period. Thus, the ability of hAChE to promote growth was associated with the presence of the E6-derived C terminus, regardless of the catalytic activity.
The E6-derived C terminus is essential for growth promotion
The ability of AChE-E6 but not AChE-I4 to promote neurite growth could be attributable to a dominant-positive effect of the AChE-E6 C terminus (conferred by a sequence and /or structural element present in this domain), or to a dominant-negative effect exerted by the I4-encoded C terminus (i.e., the I4 peptide could interfere with the growth-promoting properties of other domain(s) in the AChE core protein). This problem was examined by expressing the truncated AChE-E4 form of AChE, which retains the ACh hydrolytic activity yet lacks either the E6-or the I4-derived natural C -terminal peptides. The inability of AChE-E4 to promote growth (Table 1) proved the first option correct. Therefore, growth promotion of Xenopus spinal neurons by AChE did not require ACh hydrolytic activity; neither was it affected by the presence or absence of the I4-derived C terminus. Rather, to exert this growth-promoting activity the E6-derived synapse-characteristic C terminus must be present.
The growth promotion activity of AChE is associated with membrane interaction
Despite their sequence and biochemical similarities, AChE-E6 and AChE-I4 have previously been shown to be differentially localized in Xenopus embryos, both intra-and intercellularly (Seidman et al., 1995) . AChE-E6 was found to be associated with NMJs and AChE-I4 localized in epidermis and secreted therefrom. To compare the hydrodynamic and membrane association properties of the different recombinant hAChE variants in relation to their growth-promoting capacities, we microinjected ACHE-E4, ACHE-E6, or ACHE-I4/E5 DNAs into in vitro fertilized Xenopus eggs. Sequential extractions of injected embryos into low-salt, low-salt-detergent, and high-salt buffers yielded hAChE-containing homogenates from 1-, 2-, and 3-d-old injected Xenopus embryos. AChE catalytic activities measured in these homogenates ranged 2-to 10-fold higher than those of homogenates from uninjected embryos (data not shown) (Seidman et al., 1995) . Most importantly, the recombinant hAChE variants differed in their membrane association. Catalytically active AChE in homogenates from ACHE-E4-injected embryos was 92-95% soluble in low-salt buffer, and AChE-I4 was 74 -91% low-salt soluble (Fig. 4) , as compared with 33-53% for low-salt-soluble AChE-E6. A major fraction (20 -50%) of hAChE-E6, but no other active variant, partitioned into the low-salt-detergent fraction, reconfirming our previous reports (Seidman et al., 1995) and resembling the solubility pattern of the endogenous Xenopus enzyme (Fig. 4) . Thus, although AChE-E6 could be membraneassociated, AChE-E4 and AChE-I4 appear to be soluble proteins that could be secreted from the cells expressing them. Moreover, in all cases except AChE-E4, but including the endogenous Xenopus enzyme, there seemed to be a shift in solubility with development, from the low-salt fraction to the detergent and high-salt fractions. This shift may reflect a progressive increase in membrane interaction and association with other components, such as the extracellular matrix, at the time these components are being formed and neurons extend their neurites in vivo.
The synaptogenic and neurite growth-promoting activities of AChE are distinct
To compare the synaptogenic effect of AChE (Seidman et al., 1995) with its neurite growth-promoting capacity, we examined neuromuscular junctions (NMJs) from myotomes of 2-d-old embryos injected with the above four vectors. AChE activity staining (Seidman and Soreq, 1996) followed by transmission electron microscopy was used to assess the in vivo localization of AChE and its synaptogenic activity in Xenopus NMJs. As is apparent from the representative images of NMJs presented in Figure 5 , both AChE-E6 and the truncated AChE-E4 accumulated in NMJs in amounts exceeding those in control NMJs. High levels of catalytically active AChE, most likely of endogenous Xenopus origin, were also detected in NMJs from embryos expressing AChE-E6-IN. In contrast, AChE-I4 was absent from NMJs, confirming previous observations (Seidman et al., 1995) . These analyses demonstrated that although the E6-encoded C terminus may promote the interaction of AChE with NMJ components, it is not obligatory for NMJ accumulation of catalytically active AChE. Rather, the I4-encoded C terminus appeared to interfere dominantly with the accumulation of AChE in NMJs. Moreover, postsynaptic length measurements in 2-d-old embryos showed that transgenic expression of both AChE-E6 and the soluble AChE-E4 enlarged NMJs from an average length of 1.82 Ϯ 0.16 m (SEM; n ϭ 55) to significantly larger synapses with averages of 2.29 Ϯ 0.16 m (SEM; n ϭ 66) and 2.68 Ϯ 0.36 m (SEM; n ϭ 16), respectively ( p Ͻ 0.05; two-tailed t test). In contrast, NMJs from embryos expressing AChE-I4 or AChE-E6-IN displayed average postsynaptic lengths that were somewhat smaller yet not significantly different from that of control NMJs (1.69 Ϯ 0.19 m, SEM, n ϭ 43, and 1.41 Ϯ 0.23 m, SEM, n ϭ 31, respectively). The columns in Figure 5 depict this change, which is reflected by a shift in NMJ distribution between two groups: synapses with postsynaptic lengths smaller or larger than 2.5 m. Thus, both the synaptic accumulation and the hydrolytic capacity of the transgenic enzyme were found to be obligatory requirements for its ability to enhance NMJ development. In contrast, the synaptogenic activity of AChE was found to be unrelated to membrane association, unlike its neuritic growth-promoting function.
DISCUSSION
We used four recombinant hAChE variants to demonstrate that the neurite growth-promoting activity of AChE in cultured Xenopus neurons depends on the E6-encoded C terminus but not on catalytic activity, whereas its synaptogenic property in live Xenopus embryos depends both on its ability to accumulate within the synapse and on its hydrolytic capacity. Thus, AChE plays two distinct roles, with different mechanistic requirements, during nervous system development.
That the C terminus of hAChE modifies the electrophoretic migration properties of the enzyme under both native and denaturing conditions demonstrated that it constitutes an independent domain in the AChE protein, affecting its Stokes radius and surface charge. Human AChE-E6, AChE-I4, and AChE-E4, all of which differ in their C termini, are catalytically active (this report) and enzymatically indistinguishable (Schwarz et al., 1995a) . Cleavage of the E6-encoded C terminus does not affect the catalytic activity of Torpedo AChE (Duval et al., 1992) , which demonstrates that the C terminus is not necessary for substrate hydrolysis in vitro. Our current results further reveal that the intact catalytic activity of AChE in Xenopus laevis is C terminus independent also in vivo. Furthermore, an in-frame insertion of a foreign septapeptide near the active site serine abolished the catalytic activity of the enzyme, consistent with predictions of others (Taylor and Radic, 1994) . Neither of these alterations had an apparent effect on the amounts or the immunoreactivity of the enzyme produced in Xenopus oocytes or embryos.
The minor fast-migrating immunoreactive band produced from the hAChE-E6 and hAChE-E6-IN proteins implies partial cleavage of the C terminus encoded by E6, yielding a protein that is identical to hAChE-E4. The electrophoretic heterogeneity of hAChE-I4 and the fact that part of the hAChE-I4 protein migrated similarly to hAChE-E4 under nondenaturing gel electrophoresis further suggested that the I4-encoded C terminus could be positioned in several orientations relative to the core domain and be accessible to proteases, consistent with findings of others (Sussman et al., 1991) . However, because only minor parts of hAChE-E6 or hAChE-I4 co-migrate with hAChE-E4, we conclude that most of the former proteins indeed possessed their complete C termini.
Sequential extraction experiments demonstrated that the endogenous Xenopus enzyme and hAChE-E6 partitioned mainly a cDNA vectors were injected into Xenopus embryos at the two-cell stage using rhodamine-dextran as a marker. Cultures were made from injected embryos 1 d later. "ϩ" indicates rhodamine -dextran-positive neurons; "Ϫ" indicates rhodamine-dextran-negative neurons in the same cultures. * Significant difference was found between ϩ and Ϫ groups (two-tailed t test; p Ͻ 0.005).
Figure 4. AChE-E6 exhibits developmentally increased membrane association in vivo. Cleaving Xenopus embryos were injected with the various ACHE DNA vectors or with buffer ( C), and sequential extractions into low-salt-soluble (LSS), low-salt-detergent-soluble (DS), and high-saltsoluble (HSS) fractions were performed. Endogenous Xenopus AChE activities were subtracted from activities of all other embryo samples. Slices therefore represent the net relative fractions of the total summed activities for the host enzyme and each hAChE variant. Note that AChE-E6 is similar to Xenopus AChE in its lower solubility under low-salt extraction, whereas AChE-E4 and AChE-I4 are both predominantly low-salt soluble. Top, Schematic drawings of 1,-2-, and 3-d-old Xenopus embryos modeled after those of Deuchar (1966) .
between the low-salt and the low-salt-detergent fractions, whereas hAChE-E4 and hAChE-I4 were almost completely solubilized in low salt. These observations extend previous findings (Seidman et al., 1995) that unlike hAChE-E6, hAChE-I4 is secreted to the medium by Xenopus embryos and imply that the C terminus encoded by I4 does not contribute to the membrane interaction properties of this enzyme. Furthermore, these results are in agreement with the well known membrane association of AChE-E6 (for review, see Massoulie et al., 1993) . Therefore, of all AChE forms tested, only proteins containing the E6-derived C terminus could associate with neuronal membranes and support growth through such association. The endogenous Xenopus enzyme, which has not yet been extensively characterized or molecularly cloned, displayed hydrodynamic properties and subcellular interactions similar to those of transgenic hAChE-E6 and resembles the synaptic form of mammalian AChE encoded by ACH E-E6. Xenopus AChE is more resistant to heat and to the anticholinesterase echothiophate than the human enzyme (this report) and does not form heteromeric multimers with hAChE (Seidman et al., 1994) . However, despite these distinctions, Xenopus neurons and NMJs respond to the morphogenic activities of hAChE in an evolutionarily conserved manner. This emphasizes the importance of these functions and may allude to their early emergence in evolution.
In addition to its extracellular f unction in the hydrolysis of synaptic ACh, we demonstrate here that when intracellularly expressed, the membrane-associated AChE-E6 protein but not the alternatively spliced AChE-I4-secreted protein promotes autologous neurite extension of Xenopus neurons. Similar neurite growth activity can be induced by mutation-inactivated AChE-E6 but not by the enzymatically active truncated AChE-E4 enzyme. In cultures of chick sympathetic neurons, rat hippocampus, or retinal ganglion cells, AChE inhibitors interacting with the peripheral site of the enzyme prevented the neurite growth effect and fasciculation exerted by externally added AChE (Layer et al., 1993; Jones et al., 1995; Small et al., 1995) . However, the active site organophosphate inhibitor echothiophate, which totally inhibits cholinesterase activity, did not block AChE-induced growth. This indicated that the neurite promotion effects were not caused by enzyme activity per se. However, the effect of these pharmacological agents could be unrelated to their binding to AChE, whereas elevation of the levels of intracellularly produced AChE protein unequivocally establishes a novel noncatalytic function for this protein. Like the process extension in rat glioma cells microinjected with ACHE-E6 DNA (Karpel et al., 1996) , the neurite growth-promoting effect was spatially limited to those cells expressing the enzyme and did not extend to adjacent, non-hAChE-expressing neurons. This suggests that it involves the detergent-extractable fraction of AChE-E6 and that it is associated with membrane protein signaling.
How does AChE promote neurite growth? A group of adhesion molecules, such as neurotactin, neuroligin, and gliotactin, contain extracellular domains showing a uniformly distributed homology to cholinesterases. Their cysteine positions correspond Figure 5 . AChE-E6 and AChE-E4 enhance NMJ length, whereas AChE-I4 and AChE-E6-I N do not. Two-day-old DNA-injected and control uninjected Xenopus embryos were stained for catalytically active AChE and examined by electron microscopy. Representative images of NMJs from embryos injected with each of the vectors are shown. Note the enhanced staining apparent as dark electron-dense deposits in NMJs from AChE-E6-, AChE-E6-IN-, and AChE-E4-injected embryos as compared with controls. T, Nerve terminal; M, muscle cell; arrows points at synaptic clefts. Bottom right panel, NMJ population analysis. Electron microscope NMJ images (16, 31, 43 , and 66 sections from AChE-E4, -E6-I N, -I4, and -E6 injected and 55 sections from control uninjected embryos, respectively) were used for postsynaptic length measurements. The percentage of synapses with lengths shorter or longer than 2.5 m are presented for NMJs from embryos injected with each vector. Note that expression of AChE-E6 and AChE-E4 increases postsynaptic length as compared with controls.
